Learn more: http://www.naturalnews.com/038711_hepatitis_C_skin_reactions_drug_treatments.html#ixzz2IG8CB6u8
If
you or someone you know suffers from hepatitis C, you may want to think
twice about succumbing to conventional drug treatment options, which
could end up resulting in unexpected death. As reported by Army Times
and others, Incivek (telaprevir), a popular drug used to treat
hepatitis C, has been implicated in causing fatal skin reactions in at
least two hepatitis C patients worldwide, and the drug appears to be
especially deadly when used in combination with other hepatitis C drugs
such as Victrelis (boceprevir).
Both Incivek, which is manufactured by Vertex Pharmaceuticals, and Victrelis, which is manufactured by Merck & Co., were brought to market in 2011 to treat hepatitis C. But since that time, the U.S. Food and Drug Administration
(FDA) has received at least 112 reports of patients developing very
serious skin conditions, particularly as a result of using Incivek.
Because of this, the agency recently decided to update the package
insert for the drug, warning users about its dangers.